Q1 Earnings Forecast for IPSC Issued By HC Wainwright
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 EPS estimates for Century Therapeutics in a research note issued to investors on Tuesday, May 27th. HC Wainwright analyst M. Kapoor forecasts that the company will post earnings per share of ($0.40) for the quarter. HC Wainwright currently […]
